Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Sucralfate Oral Suspension 100009694 R01/2024
Medication labelWhy this: Advisory · dailymed-prescription
Sucralfate Oral Suspension is Sucralfate oral suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
- generic_name
- sucralfate oral
- product_names
- Sucralfate Oral
- ndc
- 52817-840, 52817-840-16
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en